Enhancement of Transdermal Drug Delivery: Integrating Microneedles with Biodegradable Microparticles
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.4c01202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Hiep X Nguyen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, Georgia 30341, United States. Hauptthemen laut MEDLINE: Drug Delivery Systems, Methotrexate. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: MilliporeSigma.
Abstract (Originalsprache)
This investigation aimed to enhance transdermal methotrexate delivery through human skin by employing Dr. Pen microneedles and poly(d,l-lactide-co-glycolide) acid microparticles formulated from eight polymer grades (Expansorb DLG 95-4A, DLG 75-5A, DLG 50-2A, DLG 50-5A, DLG 50-8A, DLG 50-6P, DLG 50-7P, and DLL 10-15A). A comprehensive characterization of the microparticles was performed, encompassing various parameters such as size, charge, morphology, microencapsulation efficiency, yield, release kinetics, and chemical composition. The efficacy of microneedles in disrupting skin integrity was demonstrated by scanning electron microscopy, dye binding, histological examination, confocal laser microscopy, and pore size analysis. Microneedle-mediated skin microporation led to a substantial reduction in skin electrical resistance and a concomitant increase in transepidermal water loss. In vitro permeation experiments using human skin delivered microparticles into microporated skin and demonstrated a considerable difference in methotrexate delivery among the polymer groups. Microneedle treatment significantly amplified cumulative drug delivery, steady-state flux, diffusion coefficient, permeability coefficient, and drug concentration within skin layers while concurrently diminishing lag time (p < 0.05). Furthermore, a robust correlation was established between microparticle properties (cumulative release, release rate, encapsulation efficiency) and drug deposition in the skin. In conclusion, the synergistic combination of Dr. Pen microneedles and PLGA microparticles facilitated enhanced and regulated transdermal methotrexate delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, Georgia 30341, United States.
- Faculty of Pharmacy, Phenikaa University, Yen Nghia, Ha Dong, Hanoi 12116, Vietnam.
- MilliporeSigma, a Business of Merck KGaA, Frankfurter Strasse 250, 64293 Darmstadt, Germany.
ORCID-Profile: Hiep X Nguyen, Ajay K Banga
Förderung
- MilliporeSigma
Zitieren
APA
Nguyen, H. X., Kipping, T., & Banga, A. K. (2025). Enhancement of Transdermal Drug Delivery: Integrating Microneedles with Biodegradable Microparticles. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01202
Vancouver
Nguyen HX, Kipping T, Banga AK. Enhancement of Transdermal Drug Delivery: Integrating Microneedles with Biodegradable Microparticles. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01202
BibTeX
@article{Nguyen2025,
author = {Nguyen, Hiep X and Kipping, Thomas and Banga, Ajay K},
title = {Enhancement of Transdermal Drug Delivery: Integrating Microneedles with Biodegradable Microparticles},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.4c01202}
}
EUVIMED